17-alpha-hydroxyprogesterone has been researched along with terbinafine in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knuth, UA; Nashan, D; Nieschlag, E; Weidinger, G | 1 |
1 trial(s) available for 17-alpha-hydroxyprogesterone and terbinafine
| Article | Year |
|---|---|
The antimycotic drug terbinafine in contrast to ketoconazole lacks acute effects on the pituitary-testicular function of healthy men: a placebo-controlled double-blind trial.
Topics: 17-alpha-Hydroxyprogesterone; Adult; Antifungal Agents; Clinical Trials as Topic; Double-Blind Method; Estradiol; Follicle Stimulating Hormone; Humans; Hydrocortisone; Hydroxyprogesterones; Ketoconazole; Luteinizing Hormone; Male; Naphthalenes; Pituitary Gland; Placebos; Terbinafine; Testis; Testosterone | 1989 |